The role of visual outcomes in MS clinical trials

被引：0
|
作者：
Balcer, L. J. [1 ]
机构：
[1] NYU, Sch Med, Neurol, New York, NY USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2014年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
TC12.3
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [1] Measures of visual pathway structure and function in MS: Clinical usefulness and role for MS trials
    Galetta, Kristin M.
    Balcer, Laura J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (03) : 172 - 182
  • [2] IMPLEMENTING VISUAL OUTCOMES IN CLINICAL TRIALS
    Brandt, Alexander
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 893 - 893
  • [3] On the role and analysis of secondary outcomes in clinical trials - Discussion
    Prentice, RL
    CONTROLLED CLINICAL TRIALS, 1997, 18 (06): : 561 - 567
  • [4] Visual spatial learning outcomes for clinical trials in neurofibromatosis type 1
    Ullrich, Nicole J.
    Payne, Jonathan M.
    Walsh, Karin S.
    Cutter, Gary
    Packer, Roger
    North, Kathryn
    Rey-Casserly, Celiane
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (02): : 245 - 249
  • [5] Vision at the limits: Absolute threshold, visual function, and outcomes in clinical trials
    Simunovic, Matthew P.
    Grigg, John R.
    Mahroo, Omar A.
    SURVEY OF OPHTHALMOLOGY, 2022, 67 (04) : 1270 - 1286
  • [6] A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS
    Hardmeier, Martin
    Leocani, Letizia
    Fuhr, Peter
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (10) : 1309 - 1319
  • [7] The long march to surrogates of meaningful clinical outcomes in MS trials Are we there yet?
    Wolinsky, J. S.
    Beck, C. A.
    NEUROLOGY, 2011, 77 (18) : 1658 - 1659
  • [8] A reconsideration of the ethics of placebo-controlled clinical trials in MS: outcomes of an international conference
    Polman, C. H.
    MULTIPLE SCLEROSIS, 2007, 13 : S17 - S17
  • [9] Clinical outcomes assessment in MS trials: on balance, the Berg Balance Scale is a precarious measure
    Hobart, J.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 365 - 366
  • [10] Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials
    Goodkin, DE
    Priore, RL
    Wende, KE
    Campion, M
    Bourdette, DN
    Herndon, RM
    Fischer, JS
    Jacobs, LD
    Cookfair, DL
    Rudick, RA
    Richert, JR
    Salazar, AM
    Granger, CV
    Simon, JH
    Alam, JJ
    Bartoszak, DM
    Braiman, J
    Brownscheidle, CM
    Coats, ME
    Cohan, SL
    Dougherty, DS
    Kinkel, RP
    Mass, MK
    Munschauer, FE
    Pullicino, PM
    Scherokman, BJ
    Weinstock-Guttman, B
    Whitham, RH
    MULTIPLE SCLEROSIS, 1998, 4 (06): : 480 - 486
12345